Reinforcing the prognostic importance of CD73 in human breast cancer, Hu et al. (2020) reported an enrichment in CD73+ γδTregs in treatment-naïve breast cancer patients that correlated with worse overall survival in TNBC, HER2+ and luminal subtypes [111]. This evidence concerns the gene ERBB2 and breast carcinoma.